Platelet Rich Plasma vs Hyaluronic-Acid in Hip OA (Osteoarthritis)

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2019

Conditions
Hip Osteoarthritis
Interventions
BIOLOGICAL

PRP

Each PRP preparation requires a total of 36 ml of peripheral blood. This will be obtained via venapuncture and collected in four 9 ml extraction tubes containing 3.8% sodium citrate. The tubes are then centrifuged at 640 rpm for 8 minutes at room temperature. The 1ml plasma fraction located above the buffy coat is aspirated from each tube and dispensed into the fractioning tube. The entire PRP process takes place under laminar airflow. Immediately prior to injection, calcium chloride is is drawn up from the activator ampoule with the activation syringe and is added to the PRP fractioning tube. The activated PRP is then injected in its entirety into the hip joint under strict aseptic technique.

DEVICE

Hyaluronic Acid

Hyaluronic acid is supplied as a non-pyrogenic solution in 2.5 ml pre-filled syringes and is administered by intra-articular injection using a 22-23 gauge needle. The full 2.5 ml is injected in one joint under strict aseptic administration.

Trial Locations (1)

80304

University of Colorado, Hip Preservation Center, Orthopedic Department, Boulder

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01920152 - Platelet Rich Plasma vs Hyaluronic-Acid in Hip OA (Osteoarthritis) | Biotech Hunter | Biotech Hunter